Key result
Cardiovagal baroreflex sensitivity from phase IV of the Valsalva maneuver was significantly lower in patients with Parkinson's disease and orthostatic hypotension compared to those with multiple-system atrophy (0.03 vs 2.86 ms/mm Hg, p=0.004).
Why the study?
Does cardiovagal baroreflex sensitivity differ between Parkinson's disease and multiple-system atrophy of the parkinsonian type in patients with orthostatic hypotension?
Cross-Sectional (n=38)
No
Does cardiovagal baroreflex sensitivity differ between Parkinson's disease and multiple-system atrophy of the parkinsonian type in patients with orthostatic hypotension?
Cardiovagal baroreflex sensitivity from phase IV of the Valsalva maneuver can help differentiate between Parkinson's disease and multiple-system atrophy in patients with orthostatic hypotension.
BACKGROUND AND PURPOSE: Parkinson's disease (PD) and multiple-system atrophy of the parkinsonian type (MSA-P) are progressive neurodegenerative disorders that in addition to dysfunction of the motor system also present with features of dysautonomia, frequently manifesting as orthostatic hypotension (OH). The pathophysiology of OH has been proposed to differ between these two disorders. This study investigated the spontaneous and cardiovagal baroreflex sensitivity (BRS) in Parkinson's disease patients with orthostatic hypotension (PD(OH)) and multiple system atrophy of Parkinsonian type with orthostatic hypotension in an attempt to differentiate the two disorders. METHODS: Two methods were used for determining the BRS: a spontaneous method (spontaneous BRS) and the reflexive baroreflex gain (cardiovagal BRS) from phases II and IV of the Valsalva maneuver (VM) in PD(OH) and MSA-P(OH). RESULTS: The spontaneous BRS (5.04±0.66 ms/mm Hg vs. 4.78±0.64 ms/mm Hg, p=0.54) and the cardiovagal BRS from phase II of the VM (0.96±0.75 ms/mm Hg vs. 1.34±1.51 ms/mm Hg, p=0.76) did not differ between PD(OH) and MSA-P(OH), but the cardiovagal BRS from phase IV of the VM (0.03±0.07 ms/mm Hg vs. 2.86±2.39 ms/mm Hg, p=0.004) was significantly lower in PD(OH). CONCLUSIONS: The cardiovagal BRS from phase IV of the VM has potential for differentiating PD(OH) and MSA-P(OH), indicating a difference in the pathophysiological mechanisms underlying the autonomic dysfunction in the two disorders.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2016) conducted a cross-sectional in Parkinson's disease and multiple-system atrophy of the parkinsonian type with orthostatic hypotension (n=38). Parkinson's disease with orthostatic hypotension vs. Multiple-system atrophy of the parkinsonian type with orthostatic hypotension was evaluated on Cardiovagal baroreflex sensitivity from phase IV of the Valsalva maneuver (p=0.004). Cardiovagal baroreflex sensitivity from phase IV of the Valsalva maneuver was significantly lower in patients with Parkinson's disease and orthostatic hypotension compared to those with multiple-system atrophy (0.03 vs 2.86 ms/mm Hg, p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: